AshishPershadMD
Cardiology • Chandler, AZAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Physician
Dr. Pershad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1727 W Frye Rd
Ste 200
Chandler, AZ 85224Phone+1 480-728-6400Fax+1 480-728-6440
Education & Training
University of Arizona College of Medicine-PhoenixFellowship, Cardiovascular Disease, 1997 - 2000
Cleveland Clinic Foundation/Fairview HospitalInternship, Internal Medicine, 1994 - 1995
Grant Medical CollegeClass of 1994
Certifications & Licensure
CA State Medical License 2000 - Present
AZ State Medical License 1997 - 2025
GA State Medical License 2021 - 2025
IA State Medical License 1996 - 1999- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Prospective Global Registry for the Study of Chronic Total Occlusion Intervention Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- Safety, feasibility, and incremental value of ultralow and zero contrast PCI in an all-comers registry.Abhishek C Sawant, Nachiket Patel, Ashish Pershad
Catheterization and Cardiovascular Interventions. 2024-10-01 - 1 citationsOptimal timing of staged percutaneous coronary intervention after subintimal tracking and re-entry: Rationale and design of the subintimal tracking and re-entry with d...Taishi Hirai, Kathleen Kearney, Lorenzo Azzalini, Adam C Salisbury, Nancy Stone
Catheterization and Cardiovascular Interventions. 2024-09-01 - 1 citationsEmbolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes.Sophie Eppinger, Kerstin Piayda, Roberto Galea, Marcus Sandri, Moniek Maarse
Cardiovascular Revascularization Medicine. 2024-07-01
Journal Articles
- Images in Intervention Software Modeling to Predict Paravalvular Leak Following Transcatheter Mitral Valve ReplacementH Kenith Fang, Ashish Pershad, Matthew Stanich, Mohamad Lazkani, ScienceDirect
Authored Content
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
Press Mentions
FDA Concerned About Higher Rates of LAA Occlusion Complications in WomenSeptember 27th, 2021- Abbott Amplatzer Amulet LAA Occluder Offers Superior Closure Compared to WatchmanAugust 31st, 2021
- FDA Clears Abbott Amplatzer Amulet LAA Occluder to Reduce Stroke in People with Atrial FibrillationAugust 16th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
